On May 20, 2023, the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Latin American Heart RhythmSociety (LAHRS) released a new clinical practice guideline on cardiac physiologic pacing strategies to restore ventricular synchr
Findings from a new clinical trial support use of implantable cardiac monitors (ICM) as a standard of care in managing patients with complex cardiac arrhythmias like atrial fibrillation (AF).
New data from a randomized clinical trial show a novel ear-clip effectively uses nerve stimulation to treat postural tachycardia syndrome (POTS). The self-administered therapy offers a noninvasive solution for patients who do not respond to existing treatment options.
The Heart Rhythm Society (HRS) announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a non-thermal ablation treatment for patients with atrial fibrillation (AF).
The Heart Rhythm Society (HRS), European Heart Rhythm Association (EHRA), Asia Pacific Heart Rhythm Society (APHRS), and Latin American Heart Rhythm Society (LAHRS) released a new expert consensus statement on the management of remote device clinics.
A novel artificial intelligence (AI) model correctly identified patients at near-term risk of life-threatening sustained ventricular tachycardia (VT) who could potentially benefit from preemptive interventions to prevent sudden cardiac death (SCD).
Results from a new clinical trial found overweight and obese patients with persistent and paroxysmal atrial fibrillation (AF) who lose weight prior to a catheter ablation procedure have improved clinical outcomes.
The Heart Rhythm Society (HRS), together with the European Heart Rhythm Association (EHRA), Asia Pacific Heart Rhythm Society (APHRS) and Latin-American Heart Rhythm Society (LAHRS) is proud to announce the Second World Forum on Cardiac Implantable Electronic Devices (CIED) Follow-up, at Heart Rh